Krishnan Patel, MD, MHS
Department of GU Radiation Oncology, Division of Radiation Oncology
Present Title & Affiliation
Primary Appointment
Associate Professor of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Dual/Joint/Adjunct Appointment
Associate Professor of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2024 | Duke University Medical Center, Durham, North Carolina, US, Clinical Research and Statistics, Master of Health Sciences |
| 2015 | Boston University School of Medicine, Boston, Massachusetts, US, Medicine, Doctorate of Medicine |
| 2010 | Duke University, Durham, North Carolina, US, B.S. in Chemistry with a Certificate of Advanced Studies in Pharmacology |
Postgraduate Training
| 2016-2020 | Chief Resident, University of Minnesota Medical Center, Minneapolis, Minnesota |
Licenses & Certifications
| 2026 | Texas Medical Board |
| 2021 | American Board of Radiology Board Certification |
| 2020 | Maryland Board of Physicians |
Experience & Service
Faculty Academic Appointments
Research Physician, Department of Radiation Oncology Department, National Cancer Institute, Bethesda, Maryland, 2022 - 2026
Radiation Oncologist, Veterans Health Administration, 2022 - 2024
Extramural Institutional Committee Activities
Reviewer, NCORP Scientific Reviewer, National Cancer Institute, 2025 - Present
Member, ABR Clinical Standards Setting Committee, ABR, 2024 - Present
Scientific Reviewer, ASTRO Genitourinary Malignancies Committee, ASTRO, 2024 - Present
Member, NCI Cancer Prevention Steering Committee, National Cancer Institute, 2024 - Present
Review Board, NCI Institutional Review Board, National Cancer Institute, 2024 - Present
Member, ASTRO Prostate Cancer Resource Committee, ASTRO, 2024 - Present
Member, NCI Genitourinary Malignancies Center for Excellence Steering Committee, National Cancer Institute, 2024 - Present
Member, NRG Oncology Early Career New Investigator Committee, NRG Oncology, 2023 - Present
Member, NCI Radiation Safety Committee, National Cancer Institute, 2022 - Present
Member, NRG Oncology Developmental Therapeutics Committee, NRG Oncology, 2022 - Present
Chair, NCI Radiation Oncology Treatment Planning Committee, National Cancer Institute, 2022 - Present
Member, NRG Oncology Genitourinary Committee, NRG Oncology, 2022 - Present
Member, National Cancer Institute Imaging Archive Advisory Committee, National Cancer Institute, 2021 - Present
Member, University of Minnesota Graduate Medical Education Committee, University of Minnesota Graduate Medical Ed, 2019 - 2020
Editorial Activities
Editor, Artificial Intelligence in Precision Oncology
Associate Genitourinary Malignancies Editor, Advances in Radiation Oncology
Honors & Awards
| 2025 - Present | The MedNet Invited Expert Panelist |
| 2024 - Present | NRG Oncology Machtay Young Investigator Award |
| 2023 - Present | ASCO ConquerCancer Career Development Award |
| 2023 - Present | NCI Institutional Review Board (IRB) Gold Star Award |
| 2023 - Present | Prostate Cancer Foundation Young Investigator Award |
| 2022 - Present | NIH Summer Research Mentor Award |
| 2021 - Present | NCI Outstanding Clinical Performance Award |
| 2021 - Present | Gold Humanism Honor Society Humanism and Excellence in Teaching Award |
| 2021 - Present | NCI Individual Special Act Award |
| 2019 - 2020 | Chief Resident, Radiation Oncology Department |
| 2018 - 2019 | University of Minnesota Board of Regents Resident Leader |
| 2007 - Present | Duke University Dean’s List Award |
Professional Memberships
Selected Presentations & Talks
Regional Presentations
- 2025. The Fundamentals of Prostate Radiation Oncology. Invited, US.
- 2025. The Application of Large Language Models to Clinical Oncology, US.
- 2023. Trimodality Therapy for Muscle Invasive Bladder Cancer, US.
- 2023. The Utility of Advanced Imaging (MRI and PSMA PET/CT) to Augment Radiotherapy for Prostate Cancer, US.
- 2023. Radiotherapy in Metastatic Prostate Cancer: from External Beam to Radiopharmaceuticals, US.
- 2017. Bladder Conservation as an Alternative to Surgical Management for Muscle-Invasive Bladder Cancer, US.
National Presentations
- 2025. The Foundations of Radiation Therapy for Urologic Malignancies, US.
- 2024. Focal Therapies and Radiation for Prostate Cancer. Los Angeles, California, US.
- 2024. NRG Oncology Genitourinary Cancer Investigator Update, US.
- 2024. Optimizing the Management of Post-Prostatectomy Biochemical Recurrence, US.
- 2023. Prostate Cancer: Technological Advances in Radiation Therapy, US.
- 2023. Prostate Cancer: The Management of Intact Prostate Cancer. Bethesda, Maryland, US.
- 2022. Prostate Cancer: Clinical Implications of Basic Science Research. Bethesda, Maryland, US.
- 2022. Spatially Fractionated Radiation Therapy. Interventional Radiology Grand Rounds. Bethesda, Maryland, US.
- 2021. American Society of Therapeutic Radiation Oncology 2021 Genitourinary Cancer Meeting Update. Bethesda, Maryland, US.
- 2021. The Post-operative Management of Biochemically Recurrent Prostate Cancer. Invited, US.
- 2021. The Staging and Management of Intact Prostate Cancer, US.
- 2021. The Basics of Therapeutic Radiation Therapy. Molecular Imaging Grand Rounds. Bethesda, Maryland, US.
Selected Publications
Peer-Reviewed Articles
- Patel KR, Nguyen PL, Proudfoot JA, Liu Y, Pra AD, Spratt DE, Pollack A, Sandler HM, Efstathiou JA, Lawton C, Simko JP, Rosenthal SA, Zeitzer KL, Mendez LC, Hartford AC, Hall WA, Desai AB, Pugh SL, Davicioni E, Tran PT, Feng FY. Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials. Eur Urol Oncol , 2026. e-Pub 2026. PMID: 39542826.
- Patel KR, Schott E, Huang EP, Cooley-Zgela T, Ning H, Cheng J, Turkbey B, Citrin DE. Salvage Stereotactic Body Radiation Therapy for Locally Recurrent Prostate Cancer: Quality-of-Life Outcomes From a Prospective Clinical Trial. Pract Radiat Oncol , 2026. e-Pub 2026. PMID: 41173140.
- Einstein DJ, Abel ML, Aragon-Ching JB, Arlen PM, Autio KA, Bilusic M, Carducci MA, Choyke PL, Citrin DE, Figg WD, Graff JN, Gulley JL, Halabi S, Karzai F, Lindenberg L, Markowski MC, Marshall CH, McNeel DG, Mena E, Moon H, Pachynski RK, Paller CJ, Patel KR, Posadas EM, Pienta KJ, Regan MM, Sena LA, Walmsley CS, Wei XX, Yu EY, Tran PT, Madan RA. National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations. J Clin Oncol, 2025. e-Pub 2025. PMID: 41129763.
- Patel KR, Pra AD, Huang EP, Singh SA, Verma V, Citrin DE, Ryckman JM. The Determinants of Toxicity in the Treatment of Prostate Cancer With a Focal, Intraprostatic "Microboost". Int J Radiat Oncol Biol Phys , 2025. e-Pub 2025. PMID: 39855400.
- Patel KR, Mena E, Rowe LS, Ning H, Cheng J, Salerno K, Schott E, Nathan D, Huang EP, Lindenberg L, Choyke P, Turkbey B, Citrin DE. A Phase 1 Trial of Image Guided Risk Volume-Adapted Postprostatectomy Radiation Therapy. Int J Radiat Oncol Biol Phys , 2025. e-Pub 2025. PMID: 39384104.
- Patel KR, Abel M, Basourakos SP, Citrin DE, Madan RA. Optimizing Radiation Therapy for Localized Prostate Cancer: Exploring Synergies With Androgen Deprivation Therapy and Novel Systemic Agents. Semin Radiat Oncol, 2025. e-Pub 2025. PMID: 40516982.
- Yilmaz EC, Harmon SA, Lis RT, Esengur OT, Gelikman DG, Garmendia-Cedillos M, Merino MJ, Wood BJ, Patel K, Citrin DE, Gurram S, Choyke PL, Pinto PA, Turkbey B. Evaluating deep learning and radiologist performance in volumetric prostate cancer analysis with biparametric MRI and histopathologically mapped slides. Abdom Radiol (NY), 2025. e-Pub 2025. PMID: 39658736.
- Patel KR, Spratt DE, Tran PT, Krauss DJ, D'Amico AV, Nguyen PL. The Benefit of Short-Term Androgen Deprivation Therapy with Radiation Therapy for Intermediate-Risk Prostate Cancer. Meta-Analysis, 2025. e-Pub 2025. PMID: 39922318.
- Patel KR, Hall WA. Maximum Surgical Resection Followed by Radiation Therapy for the Management of Mucinous Adenocarcinoma of the Prostate. Int J Radiat Oncol Biol Phys , 2025. e-Pub 2025. PMID: 39909606.
- Patel KR, Menon H, Patel RR, Huang EP, Verma V, Escorcia FE. Locoregional Therapies for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. JAMA Netw Open, 2024. e-Pub 2024. PMID: 39602117.
- Patel KR, der Heide UAV, W Kerkmeijer LG, Schoots IG, Turkbey B, Citrin DE, Hall WA. Target Volume Optimization for Localized Prostate Cancer. Pract Radiat Oncol , 2024. e-Pub 2024. PMID: 39019208.
- Patel KR, Rydzewski NR, Schott E, Cooley-Zgela T, Ning H, Cheng J, Salerno K, Huang EP, Lindenberg L, Mena E, Choyke P, Turkbey B, Citrin DE. A Phase 1 Trial of Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer After Brachytherapy. Int J Radiat Oncol Biol Phys , 2024. e-Pub 2024. PMID: 38428681.
- Zhang S, Patel K, Dusenbery K, Alshreef A, Sterling D, Sloan L, Reynolds M, Chen CC, Ferreira C. Dosimetric evaluation and treatment planning considerations for GammaTile permanent brain implants - a pilot, institutional experience. J Neurooncol, 2024. e-Pub 2024. PMID: 38902561.
- Johnson LA, Harmon SA, Yilmaz EC, Lin Y, Belue MJ, Merriman KM, Lay NS, Sanford TH, Sarma KV, Arnold CW, Xu Z, Roth HR, Yang D, Tetreault J, Xu D, Patel KR, Gurram S, Wood BJ, Citrin DE, Pinto PA, Choyke PL, Turkbey B. Automated prostate gland segmentation in challenging clinical cases: comparison of three artificial intelligence methods. Abdom Radiol (NY) , 2024. e-Pub 2024. PMID: 38512516.
- Rydzewski NR, Dinakaran D, Zhao SG, Ruppin E, Turkbey B, Citrin DE, Patel KR. Comparative Evaluation of LLMs in Clinical Oncology. NEJM AI, 2024. e-Pub 2024. PMID: 39131700.
- Lee KH, Mena E, Shih J, Lindenberg L, Wood BJ, Pinto PA, Patel KR, Citrin DE, Choyke PL, Turkbey B. Predicting 18F-DCFPyL-PET/CT Scan Positivity in Prostate Cancer Patients with Biochemical Recurrence, 2024. e-Pub 2024. PMID: 37775447.
- Rydzewski NR, Shi Y, Li C, Chrostek MR, Bakhtiar H, Helzer KT, Bootsma ML, Berg TJ, Harari PM, Floberg JM, Blitzer GC, Kosoff D, Taylor AK, Sharifi MN, Yu M, Lang JM, Patel KR, Citrin DE, Sundling KE, Zhao SG. A platform-independent AI tumor lineage and site (ATLAS) classifier. Commun Biol , 2024. e-Pub 2024. PMID: 38480799.
- Yilmaz EC, Lin Y, Belue MJ, Harmon SA, Phelps TE, Merriman KM, Hazen LA, Garcia C, Johnson L, Lay NS, Toubaji A, Merino MJ, Patel KR, Parnes HL, Law YM, Wood BJ, Gurram S, Choyke PL, Pinto PA, Turkbey B. PI-RADS Version 2.0 Versus Version 2.1: Comparison of Prostate Cancer Gleason Grade Upgrade and Downgrade Rates From MRI-Targeted Biopsy to Radical Prostatectomy. AJR Am J Roentgenol, 2024. e-Pub 2024. PMID: 37729551.
- Yilmaz EC, Harmon SA, Belue MJ, Merriman KM, Phelps TE, Lin Y, Garcia C, Hazen L, Patel KR, Merino MJ, Wood BJ, Choyke PL, Pinto PA, Citrin DE, Turkbey B. Evaluation of a Deep Learning-based Algorithm for Post-Radiotherapy Prostate Cancer Local Recurrence Detection Using Biparametric MRI. Eur J Radiol , 2023. e-Pub 2023. PMID: 37717420.
- Yilmaz EC, Harmon SA, Belue MJ, Merriman KM, Phelps TE, Lin Y, Garcia C, Hazen L, Patel KR, Merino MJ, Wood BJ, Choyke PL, Pinto PA, Citrin DE, Turkbey B. Evaluation of a Deep Learning-based Algorithm for Post-Radiotherapy Prostate Cancer Local Recurrence Detection Using Biparametric MRI. Eur J Radiol , 2023. e-Pub 2023. PMID: 37442430.
- Trotta M, Patel KR, Singh S, Verma V, Ryckman J. Safety of Radiation Therapy in Patients With Prostate Cancer and Inflammatory Bowel Disease: A Systematic Review. Pract Radiat Oncol , 2023. e-Pub 2023. PMID: 37100389.
- Belue MJ, Harmon SA, Patel K, Daryanani A, Yilmaz EC, Pinto PA, Wood BJ, Citrin DE, Choyke PL, Turkbey B. Development of a 3D CNN-based AI Model for Automated Segmentation of the Prostatic Urethra. Acad Radiol , 2022. e-Pub 2022. PMID: 35183438.
- Salerno KE, Turkbey B, Lindenberg L, Mena E, Schott EE, Brennan AK, Roy S, Shankavaram U, Patel K, Cooley-Zgela T, McKinney Y, Wood BJ, Pinto PA, Choyke P, Citrin DE. Detection of failure patterns using advanced imaging in patients with biochemical recurrence following low-dose-rate brachytherapy for prostate cancer. Brachytherapy , 2022. e-Pub 2022. PMID: 35523680.
- Patel KR, Rowe LS, Schott E, Cooley-Zgela T, Ning H, Turkbey B, Choyke P, Lindenberg L, Mena E, Pinto PA, Zhang Q, Shih J, Salerno KE, Citrin DE. A Phase 1 Trial of Highly Conformal, Hypofractionated Postprostatectomy Radiation Therapy. Adv Radiat Oncol , 2022. e-Pub 2022. PMID: 36420197.
- Patel KR, Saad W, Heller T, Turkbey B, Citrin DE. Postprostatectomy Radiation Therapy in the Setting of a Rectal Vascular Malformation. Adv Radiat Oncol , 2022. e-Pub 2022. PMID: 36060633.
- Patel KR, Rowe LS, Schott E, Cooley-Zgela T, Ning H, Turkbey B, Choyke P, Lindenberg L, Mena E, Pinto PA, Zhang Q, Shih J, Salerno KE, Citrin DE. A Phase 1 Trial of Highly Conformal, Hypofractionated Postprostatectomy Radiation Therapy. Adv Radiat Oncol , 2022. e-Pub 2022. PMID: 36420197.
- Goyal A, O'Leary D, Goyal K, Patel K, Pearson D, Janakiram M. Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer. J Am Acad Dermatol , 2021. e-Pub 2021. PMID: 32822803.
- Goyal A, Marghitu T, Goyal N, Rubin N, Patel K, Goyal K, O'Leary D, Bohjanen K, Maher I. Surgical management and lymph-node biopsy of rare malignant cutaneous adnexal carcinomas: a population-based analysis of 7591 patients. Arch Dermatol Res , 2021. e-Pub 2021. PMID: 32965516.
- Basourakos SP, Tzeng M, Lewicki PJ, Patel K, Al Awamlh BAH, Venkat S, Shoag JE, Gorin MA, Barbieri CE, Hu JC. Tissue-Based Biomarkers for the Risk Stratification of Men With Clinically Localized Prostate Cancer. Front Oncol , 2021. e-Pub 2021. PMID: 34123846.
- Patel K. Mycosis fungoides: developments in incidence, treatment and survival. J Eur Acad Dermatol Venereol, 2020. e-Pub 2020. PMID: 32141115.
- Mattes MD, Patel KR, Burt LM, Hirsch AE. A Nationwide Medical Student Assessment of Oncology Education. J Cancer Educ, 2016. e-Pub 2016. PMID: 26123764.
Patient Reviews
CV information above last modified May 20, 2026